Commodore Capital LP

Search
⚲

Total AUM ($MM) Copy

CIK	Period
0001831942
/

Sector	Form 13F Holdings	Cap ($MM)	Value ($MM)
	Xenon Pharmaceuticals Inc	1,599.0	66.0
	Signal Genetics Inc	293.2	55.7
	Merus NV	941.6	54.3
	UNUM Therapeutics Inc	567.1	51.5
	Bellus Health Inc	1,001.3	47.4
	Ambrx Biopharma Inc	101.9	42.8
	Akero Therapeutics Inc	368.0	30.2
	Nuvalent Inc	644.5	28.0
	Health Sciences Acquisitions Corp	331.3	22.3
	Vera Therapeutics Inc	360.7	21.9
	Syndax Pharmaceuticals Inc	1,042.0	18.0
	Celldex Therapeutics Inc	1,341.4	17.8
	CymaBay Therapeutics Inc	232.0	17.7
	Cabaletta Bio Inc	30.1	15.2
	Zeta Acquisition Corp III	1,163.5	14.7
	Arrowhead Research Corp	3,433.3	14.6
	Celcuity Inc	128.6	14.3
	Prometheus Biosciences Inc	1,078.7	13.6
	Nivalis Therapeutics Inc	244.1	10.2
	Day One Biopharmaceuticals Inc	1,231.1	9.9
	Avidity Biosciences Inc	704.2	9.1
	Enanta Pharmaceuticals Inc	922.8	8.8
	Allakos Inc	176.9	8.5
	Vaxcyte Inc	1,215.3	7.5
	Aclaris Therapeutics Inc	936.1	5.1
	Avalanche Biotechnologies Inc	115.6	3.6
	Carbylan Therapeutics Inc	236.1	2.5
	FITS My Style Inc	112.2	1.7



Prev \| Page 1 \| Next

Type	Form D Funds	Date	Sold ($MM)	AUM ($MM)
HF	Commodore Capital Master LP	[2019-07-15]	535.6	814.6

AUM Breakdown	Accounts	AUM ($MM)
By Client Type
(a) Individuals (other than high net worth individuals)	0	0.0
(b) Individuals (high net worth individuals)	0	0.0
(c) Banking or thrift institutions	0	0.0
(d) Investment companies	0	0.0
(e) Business development companies	0	0.0
(f) Pooled investment vehicles	3	814.6
(g) Pension and profit sharing plans	0	0.0
(h) Charitable organizations	0	0.0
(i) State or municipal government entities	0	0.0
(j) Other investment advisers	0	0.0
(k) Insurance companies	0	0.0
(l) Sovereign wealth funds and foreign official institutions	0	0.0
(m) Corporations or other businesses not listed above	0	0.0
(n) Other	0	0.0
Total	3	814.6
By Discretionary
Discretionary	3	814.6
Non-Discretionary	0	0.0
Total	3	814.6
By Non-United States Persons
Non-United States Persons		140.3
United States Persons		674.4
Total	3	814.6

Form D Directors	# Filings	# Firms	2011 - 2024
Egen Atkinson	2
Commodore Capital LP	2
Michael Kramarz	2
Commodore Capital Domestic GP LP	1

Form 13D/13G Filer	Form 13D/13G Subject	Filed
Commodore Capital LP	Enliven Therapeutics Inc	[2023-04-24]
Commodore Capital LP	Adverum Biotechnologies Inc	[2023-04-20]
Commodore Capital LP	Bellus Health Inc	[2023-03-30]
Commodore Capital LP	Ambrx Biopharma Inc	[2023-03-03]
Commodore Capital LP	Vera Therapeutics Inc	[2023-02-16]
Commodore Capital LP	Cabaletta Bio Inc	[2023-01-13]
Commodore Capital LP	Imara Inc	[2022-10-24]
Commodore Capital LP	Immunic Inc	[2022-10-21]
Commodore Capital LP	Viridian Therapeutics Inc de	[2022-05-19]
Commodore Capital LP	Merus NV	[2022-05-16]
View All

Form 3/4/5 Subject	2011 - 2024
Ambrx Biopharma Inc.
Commodore Capital LP
Enliven Therapeutics, Inc.
Satsuma Pharmaceuticals, Inc.

Comparable Firms	State	AUM ($BB)
Sandia Investment Managment LP ✚	MA	0.8
Hercules Adviser LLC ✚	CA	0.8
Emerson Point Capital LP ✚	NY	0.8
JB Investments Management LLC ✚	PA	0.8
Hitchwood Capital Management LP ✚	NY	0.8
Foursixthree Capital LP ✚	NY	0.8
Acuitas Investments LLC ✚	WA	0.8
Moerus Capital Management LLC ✚	NY	0.8
Baymount Management LP ✚	FL	0.8
Sunriver Management LLC ✚	CT	0.8

Assets, Funds, Holdings